IRUBIS

We are combining semiconductor technology and infrared spectroscopy to build a device that analyses protein based drugs faster and better than conventional devices. Our customers will be research institutes, universities, and pharma companies.

IRUBIS is a company in vc portfolio based in Germany, founded in 2022.

IRUBIS is positioned in vc portfolio, a segment that rewards a clear, focused offering.

Its base of operations is Germany.

Its current recorded stage is VC-backed startup.

Website: irubis.com